Opinion Review
Copyright ©The Author(s) 2022.
World J Gastroenterol. Oct 21, 2022; 28(39): 5658-5665
Published online Oct 21, 2022. doi: 10.3748/wjg.v28.i39.5658
Table 1 Regions where small intestinal adenocarcinoma was reported
Country
Year
Number1
Duodenum
Jejunum
Ileum
Ref.
France202034721060.6%7220.7%6518.7%[31]
China20204211226.2%2969.0%24.8%[15]
Japan2015471429.8%2144.7%1225.5%[32]
United States201042123054.6%14233.7%4911.7%[33]
China201019710854.8%5929.9%3015.3%[34]
United States200646027259.1%9821.3%9019.6%[35]
United States200519511357.9%5427.7%2814.4%[7]
United States1996140477755.3%37626.8%25117.9%[2]
JapanOur cases5032040.0%2652.0%48.0%N/A
Table 2 Risk factors for small intestinal adenocarcinoma
Factor
Disease
Risks of small intestinal adenocarcinoma
Ref.
Animal fatCorrelation coefficient of 0.61[21]
Animal proteinCorrelation coefficient of 0.75[21]
2–3-fold higher risk[36]
Bile saltsBile salts may transform into carcinogenic deoxycholic acid[22]
Hereditary polyposisFAPAPC mutation; 5% is small bowel adenocarcinoma and half is duodenal adenocarcinoma[27]
The incidence is 330 times higher than that in the general population[28]
HNPCCMMR gene mutation; lifetime risk is at approximately 1% in a French registry[29]
PJSSTK11 mutation; incidence is 520 times higher than that in the general population[30]
DiseaseCrohn’s diseaseThe incidence is 17.4 times higher than that in the general population[37]
The incidence is almost 3 times higher than that in the average American[38]
Celiac diseaseIt is implicated in 8%-13% of small bowel adenocarcinoma cases[39,40]